Kyntra Bio (KYNB) Non-Current Deferred Tax Liability (2018 - 2021)

Kyntra Bio has reported Non-Current Deferred Tax Liability for 4 years, with the latest figure at $9.2 million in Q4 2021.

• Quarterly Non-Current Deferred Tax Liability rose 5.96% year-over-year to $9.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $9.2 million (up 5.96% YoY) and the FY2021 annual result came in at $9.2 million, up 5.96% from the prior year.
• Non-Current Deferred Tax Liability rose to $9.2 million in Q4 2021 per KYNB's latest filing, from $9.1 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $9.2 million in Q4 2021 and troughed at $8.1 million in Q4 2018.
• A 4-year average of $8.8 million and a median of $8.8 million in 2019 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2019 and 2020: Non-Current Deferred Tax Liability rose 9.52% in 2019, then slipped 2.67% in 2020.
• Over 4 years, Non-Current Deferred Tax Liability stood at $8.1 million in 2018, then rose by 9.52% to $8.9 million in 2019, then slipped by 2.67% to $8.7 million in 2020, then increased by 5.96% to $9.2 million in 2021.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $9.2 million, $9.1 million, and $9.0 million for Q4 2021, Q3 2021, and Q2 2021 respectively.